In addition, mutations in exon 20, coding for the TKD2 region (most frequently affecting codons D835 and I836), can be detected in 7%–10% of AML patients (FLT3-TKD) (1, 2). This evidence concerns the gene FLT3 and acute myeloid leukemia.